Mark H. Pavao
Acting Chief Commercial OfficerMr. Mark H. Pavao serves as the Chief Executive Officer and President of R Pharm US LLC. Mr. Pavao serves as Member of Advisory Board at 108 BioCapital. Mr. Pavao served as Senior Vice President of Sales & Marketing for Nitromed Inc., since July 2004. Mr. Pavao was responsible for ensuring the integration of Nitromed Inc.'s clinical, regulatory, manufacturing and marketing and sales resources. He is Independent Director of Coya Therapeutics, Inc. since April 2026. He is Director of Perosphere Technologies Inc. and MiracleFeet. Mr. Pavao serves as Chair of the Board of Medical Knowledge Group. Mr. Pavao has held senior leadership roles at Biotech Value Advisors, LLC. He joined NitroMed from Bristol Myers Squibb where he served as Vice President of Neuroscience Marketing. Mr. Pavao served as Vice President of Neuroscience Marketing for Bristol Myers Squibb Company, a pharmaceuticals and health care products company from August 2001 to July 2004. Mr. Pavao served as Vice President of Sales & Marketing for Helios Health, Inc., a provider of Internet connected patient education kiosks from February 2000 to May 2001. From 1989 to 2000 Mr. Pavao served various positions at SmithKline Beecham Pharmaceuticals, a Pharmaceuticals Company, culminating in his service as Vice President of Healthcare Initiatives from September 1999 to February 2000. He served as Vice President of Marketing for the Neuroscience Division at Bristol Myers Squibb, Mr. Pavao was responsible for the launch of Abilify(R), which was recognized as one of the top ten pharmaceutical product launches based on sales achieved in the first year on the market. Mr. Pavao holds a B.A. from the University of North Carolina at Chapel Hill and an M.B.A. from The Wharton School at the University of Pennsylvania.
Positions
- Company NameBioXcel Therapeutics, Inc.Stock CodeBTAIQPositionActing Chief Commercial OfficerColleagues
- VDVimal D. MehtaFounder & Director
- PRPeter R. MuellerIndependent Chairman & Lead Director
- SSSamir SaleemPresident, Secretary, Principal Executive Officer & Chief Restructuring Officer
- MMMatt MandelVice President of Clinical Development
- SLSandeep LaumasIndependent Director
- SMSteven M. PaulMember of Advisory Board
- SKSheila K. GujrathiMember of Advisory Board
